This trial uses 68Ga-PSMA-11 PET scans to find out if it can help doctors learn more about where disease is located in the body for patients with prostate cancer who have had their testes removed or have been castrated.
4 Primary · 4 Secondary · Reporting Duration: Up to 24 months
110 Total Participants · 1 Treatment Group
Primary Treatment: 68Ga-PSMA-11 · No Placebo Group · Phase 2
Age 18+ · Male Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: